{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:17:19Z","timestamp":1768745839927,"version":"3.49.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/15687-5"],"award-info":[{"award-number":["2020\/15687-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["140695\/2019-2"],"award-info":[{"award-number":["140695\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110723","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T17:07:20Z","timestamp":1690823240000},"page":"110723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad\u00ae immunotherapy associated with platelet-rich plasma"],"prefix":"10.1016","volume":"123","author":[{"given":"Bianca","family":"Ribeiro de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ianny","family":"Brum Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Cardoso de Arruda Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-1836","authenticated-orcid":false,"given":"Gabriela","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Queila","family":"Cristina Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-5143","authenticated-orcid":false,"given":"Nelson","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner","family":"Jos\u00e9 F\u00e1varo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110723_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) -, Update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/181987","article-title":"Bladder cancer immunotherapy: BCG and beyond","author":"Askeland","year":"2012","journal-title":"Adv. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0015","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis), Update","volume":"178","author":"Hall","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0020","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2005-03-1327","article-title":"Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) results in the release of functional soluble TRAIL\/Apo-2L","volume":"106","author":"Kemp","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110723_b0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"B\u00f6hle","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0030","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.eururo.2007.04.062","volume":"52","author":"Ojea","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061449","article-title":"Current strategies and novel therapeutic approaches for metastatic urothelial carcinoma","volume":"12","author":"Mollica","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2023.110723_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.intimp.2023.110723_b0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00262-022-03349-4","article-title":"Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis","volume":"72","author":"Santoni","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2023.110723_b0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.euf.2021.01.003","article-title":"Expression of programmed cell death ligand 1 as a predictive biomarker in metastatic urothelial carcinoma patients treated with first-line immune checkpoint inhibitors versus chemotherapy: a systematic review and meta-analysis","volume":"8","author":"Rizzo","year":"2022","journal-title":"Eur. Urol. Focus."},{"key":"10.1016\/j.intimp.2023.110723_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103596","article-title":"The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: the MOUSEION-01 study","volume":"170","author":"Santoni","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2023.110723_b0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ygyno.2014.08.013","article-title":"Role of Toll-like receptors in cervical, endometrial and ovarian cancers: a review","volume":"135","author":"Husseinzadeh","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.intimp.2023.110723_b0065","article-title":"P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling, Journal of Ovarian","volume":"11","author":"de A. Chuffa","year":"2018","journal-title":"Research"},{"key":"10.1016\/j.intimp.2023.110723_b0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110723_b0075","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.0902401","article-title":"TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types","volume":"184","author":"Galli","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110723_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2023.110723_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0040-2016","article-title":"Toll-like receptor signaling and its inducible proteins","volume":"4","author":"Satoh","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.intimp.2023.110723_b0090","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.juro.2010.12.097","article-title":"Toll-like receptors in normal and malignant human bladders","volume":"185","author":"Ayari","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4236\/jct.2015.62014","article-title":"Molecular assessment of non-muscle invasive and muscle invasive bladder tumors: mapping of putative urothelial stem cells and toll-like receptors (TLR) signaling","volume":"06","author":"Stopiglia","year":"2015","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.intimp.2023.110723_b0100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-5347(01)65921-4","article-title":"Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin","volume":"156","author":"Sander","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.juro.2006.09.074","article-title":"Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64","volume":"177","author":"Yu","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0110","unstructured":"W.J. F\u00e1varo, N.E.D. Caballero, PROCESS FOR OBTAINING NANOSTRUCTURED COMPLEX (CFI-1), NANOSTRUCTURED COMPLEX ASSOCIATED WITH PROTEIN (MRB-CFI-1), BR:102017012768:B1, 2022. https:\/\/patentimages.storage.googleapis.com\/dd\/0e\/84\/5ce8e5594dd259\/BR102017012768B1.pdf (accessed March 12, 2023)."},{"key":"10.1016\/j.intimp.2023.110723_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101988","article-title":"New synthetic nano-immunotherapy (OncoTherad\u00ae) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property","volume":"80","author":"F\u00e1varo","year":"2023","journal-title":"Tissue Cell"},{"key":"10.1016\/j.intimp.2023.110723_b0120","unstructured":"W.J. Favaro, N.E.D. Caballero, Method for producing a nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CFI-1) and use, 11136242, 2021. https:\/\/patentimages.storage.googleapis.com\/a9\/1b\/77\/72686d2d9d735a\/US11136242.pdf (accessed March 12, 2023)."},{"key":"10.1016\/j.intimp.2023.110723_b0125","unstructured":"W.J. Favaro, N.E.D. Caballero, A method for producing a nanostructured complex (cfi-1), a protein-associated nanostructured complex (mrb-cfi-1) and use, 2018227261:A1, 2018. https:\/\/patentimages.storage.googleapis.com\/86\/31\/02\/47260fe9b358c9\/WO2018227261A1.pdf (accessed March 12, 2023)."},{"key":"10.1016\/j.intimp.2023.110723_b0130","unstructured":"REBEC, (n.d.). https:\/\/ensaiosclinicos.gov.br\/rg\/RBR-6swqd2 (accessed March 12, 2023)"},{"key":"10.1016\/j.intimp.2023.110723_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101762","article-title":"OncoTherad\u00ae (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway","volume":"76","author":"Reis","year":"2022","journal-title":"Tissue Cell."},{"key":"10.1016\/j.intimp.2023.110723_b0140","doi-asserted-by":"crossref","first-page":"e16551","DOI":"10.1200\/JCO.2022.40.16_suppl.e16551","article-title":"Crosstalk among T-cell CX3CR1, immune checkpoints and toll-like receptor 4 signaling pathway in BCG-unresponsive nonmuscle invasive bladder cancer: mechanism of action of oncotherad nano-immunotherapy","volume":"40","author":"Alonso","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110723_b0145","doi-asserted-by":"crossref","first-page":"e17048","DOI":"10.1200\/JCO.2020.38.15_suppl.e17048","article-title":"Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Gu\u00e9rin-unresponsive non\u2013muscle invasive bladder cancer: Results from phase I\/ II study","volume":"38","author":"Alonso","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110723_b0150","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110723_b0155","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-021-21619-0","article-title":"T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors","volume":"12","author":"Yamauchi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110723_b0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110723_b0165","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/term.2832","article-title":"Platelet-rich plasma, a powerful tool in dermatology","volume":"13","author":"Merch\u00e1n","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.intimp.2023.110723_b0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: a review and author\u2032s perspective","volume":"7","author":"Dhurat","year":"2014","journal-title":"J. Cutan. Aesthet Surg."},{"key":"10.1016\/j.intimp.2023.110723_b0175","first-page":"305","article-title":"Autologous platelet concentrates in maxillofacial regenerative therapy, Kaohsiung","volume":"36","author":"Chou","year":"2020","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.intimp.2023.110723_b0180","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11033-020-05297-7","article-title":"Adipose derived stem cells and platelet rich plasma improve the tissue integration and angiogenesis of biodegradable scaffolds for soft tissue regeneration","volume":"47","author":"Naderi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2023.110723_b0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tice.2018.03.011","article-title":"Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Gu\u00e9rin (BCG) in non-muscle invasive bladder cancer","volume":"52","author":"Dias","year":"2018","journal-title":"Tissue Cell."},{"key":"10.1016\/j.intimp.2023.110723_b0190","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12185-012-1054-5","article-title":"Polyphosphate: a link between platelets, coagulation and inflammation","volume":"95","author":"Morrissey","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.intimp.2023.110723_b0195","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2023.110723_b0200","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2013-07-515726","article-title":"Polyphosphate suppresses complement via the terminal pathway","volume":"123","author":"Wat","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110723_b0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12885-016-2474-z","article-title":"Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier","volume":"16","author":"Garcia","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2023.110723_b0210","unstructured":"National Research Council, Division on Earth and Life Studies, Institute for Laboratory Animal Research, Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals: Eighth Edition, National Academies Press, 2011. https:\/\/books.google.com\/books\/about\/Guide_for_the_Care_and_Use_of_Laboratory.html?hl=&id=GyxkAgAAQBAJ."},{"key":"10.1016\/j.intimp.2023.110723_b0215","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The world health organization\/international society of urological pathology consensus classification of urothelial (Transitional Cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.intimp.2023.110723_b0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nutres.2007.12.002","article-title":"Naringenin reduces tumor size and weight lost in N-methyl-N\u2019-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats","volume":"28","author":"Ekambaram","year":"2008","journal-title":"Nutr. Res."},{"key":"10.1016\/j.intimp.2023.110723_b0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cbi.2007.09.003","article-title":"Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin","volume":"171","author":"Sivaramakrishnan","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2023.110723_b0230","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s004670000551","article-title":"Measurement of urinary concentration: a critical appraisal of methodologies","volume":"16","author":"Chadha","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2023.110723_b0235","first-page":"172","article-title":"Some pharmacological studies of ciproflo, Zagazig","volume":"45","author":"Abdel-Alim","year":"2017","journal-title":"Vet. J."},{"key":"10.1016\/j.intimp.2023.110723_b0240","first-page":"87","volume":"15","author":"de Oliveira Cezar","year":"2012","journal-title":"Avalia\u00e7\u00e3o da Compatibilidade entre Bulas de Diferentes Marcas de Tiras Reagentes de Urina, RBM"},{"key":"10.1016\/j.intimp.2023.110723_b0245","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/0192623312438736","article-title":"Proliferative and nonproliferative lesions of the rat and mouse urinary system","volume":"40","author":"Frazier","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2023.110723_b0250","doi-asserted-by":"crossref","first-page":"e1005848","DOI":"10.1371\/journal.ppat.1005848","article-title":"Molecular Basis of acute cystitis reveals susceptibility genes and immunotherapeutic targets","volume":"12","author":"Ambite","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2023.110723_b0255","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2214\/AJR.09.2344","article-title":"Exploring a new paradigm for imaging of bladder cancer","volume":"192","author":"Cohan","year":"2009","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.intimp.2023.110723_b0260","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00261-009-9540-9","article-title":"Diagnosis of bladder cancer: contrast-enhanced ultrasound","volume":"35","author":"Nicolau","year":"2010","journal-title":"Abdom Imaging."},{"key":"10.1016\/j.intimp.2023.110723_b0265","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1118\/1.1418726","article-title":"Detection of tumorigenesis in rat bladders with optical coherence tomography","volume":"28","author":"Pan","year":"2001","journal-title":"Med. Phys."},{"key":"10.1016\/j.intimp.2023.110723_b0270","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1323\/1\/012022","article-title":"New therapeutic perspective for bladder cancer in dogs: toxicological and clinical effects of OncoTherad nanostructured immunotherapy","volume":"1323","author":"B\u00f6ckelmann","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.intimp.2023.110723_b0275","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2023.110723_b0280","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1182\/blood-2012-03-306605","article-title":"Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation","volume":"119","author":"Morrissey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110723_b0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrurol.2013.153","article-title":"Toll-like receptors in urothelial cells\u2013targets for cancer immunotherapy","volume":"10","author":"LaRue","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0290","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.10290","article-title":"MHC class I antigens, immune surveillance, and tumor immune escape","volume":"195","author":"Garcia-Lora","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.110723_b0295","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0929-6646(10)60050-2","article-title":"HLA-G and immune evasion in cancer cells","volume":"109","author":"Sheu","year":"2010","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.intimp.2023.110723_b0300","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/1078-0432.CCR-07-1654","article-title":"Transforming growth factor-beta and the immune response to malignant disease","volume":"13","author":"Teicher","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2023.110723_b0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00432-008-0478-z","article-title":"Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling","volume":"135","author":"Qian","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110723_b0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-9378-7-14","article-title":"Effects of P-MAPA immunomodulator on toll-like receptors and p53: potential therapeutic strategies for infectious diseases and cancer","volume":"7","author":"F\u00e1varo","year":"2012","journal-title":"Infect. Agent. Cancer."},{"key":"10.1016\/j.intimp.2023.110723_b0315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imm.12306","article-title":"Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner","volume":"143","author":"Kumar","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2023.110723_b0320","first-page":"4427","article-title":"Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer","volume":"8","author":"Garcia","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.intimp.2023.110723_b0325","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110723_b0330","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.intimp.2009.09.012","article-title":"Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4","volume":"9","author":"Takeuchi","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110723_b0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.carbpol.2014.11.012","article-title":"Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma","volume":"118","author":"Zhang","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.intimp.2023.110723_b0340","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1016-4","article-title":"A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells","volume":"60","author":"Lin","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2023.110723_b0345","article-title":"Clitocybe nuda activates dendritic cells and acts as a DNA vaccine adjuvant","author":"Chen","year":"2013","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2023.110723_b0350","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4049\/jimmunol.179.3.1568","article-title":"Cross-talk between T cells and innate immune cells is crucial for IFN-gamma-dependent tumor rejection","volume":"179","author":"Li","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110723_b0355","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/01.ju.0000168619.25341.96","article-title":"Interferon-gamma up-regulates toll-like receptor 4 and cooperates with lipopolysaccharide to produce macrophage-derived chemokine and interferon-gamma inducible protein-10 in human bladder cancer cell line RT4","volume":"174","author":"Yamada","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2023.110723_b0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2023.110723_b0365","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1157023","article-title":"Toll-Like Receptors (TLRs): structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility","author":"Sameer","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2023.110723_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.02.018","article-title":"Cancer relapse under chemotherapy: why TLR2\/4 receptor agonists can help","volume":"563","author":"Garay","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110723_b0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark Res."},{"key":"10.1016\/j.intimp.2023.110723_b0380","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2021.03.007","article-title":"Role of pyroptosis in cancer cells and clinical applications","volume":"185","author":"Ju","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2023.110723_b0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.4892","article-title":"High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival","volume":"242","author":"Roudnicky","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2023.110723_b0390","first-page":"2381","article-title":"Expression of VEGF and its receptors VEGFR1\/VEGFR2 is associated with invasiveness of bladder cancer","volume":"33","author":"Kopparapu","year":"2013","journal-title":"Anticancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:32:28Z","timestamp":1736433148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923010482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":78,"alternative-id":["S1567576923010482"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110723","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad\u00ae immunotherapy associated with platelet-rich plasma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110723"}}